ChemBridge Corporation is a global provider of enabling chemistry products and contract research services for small molecule drug discovery, chemical biology, and agrochemical discovery programs. ChemBridge actively designs and synthesizes novel lead-like and drug-like screening compounds and novel synthetic macrocycles based on proprietary internal designs inspired by the latest scientific publications and collaborations with external scientists. Our extensive portfolio includes over 1.3 million diverse and target-focused small molecule screening compounds, more than 15,000 novel, synthetic macrocycles, over 14,000 chemical building blocks, our Hit2Lead.com online chemical store, and high-end, research-intensive custom library and synthetic/medicinal chemistry services. We have delivered millions of screening compounds, macrocycles, fragments, and building blocks to pharmaceutical, biotechnology, and academic/non-profit organizations worldwide. These compounds have supported small molecule drug discovery and chemical biology programs in industry and academia. They have enabled many scientific discoveries, featured in over 2,600 publications in leading research journals.

🔗 http://chembridge.com

CONNECT:

Vangie Santos
📧 vangie@chembridge.com
📞 858.451.7400
11199 Sorrento Valley Rd., Suite 206
San Diego, CA 92121